Synthetic peptide derived from the N-terminal region of human FZD2.
Our Abpromise guarantee covers the use of ab52565 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 - 3 µg/ml. Detects a band of approximately 85 kDa (predicted molecular weight: 63 kDa). The observed molecular weight of ~ 85 kDa may be due to post-translational modifications such as glycosylation, which is predicted in the amino acid sequence.|
|IP||Use at an assay dependent dilution. Use at a concentration of 7 µg/reaction.|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"